Formats
  1. Journal Article (66949)
  2. Meeting Abstract (33621)
  3. Book Section (5116)
  4. Review (3791)
  5. Editorial (2196)
  6. Conference Paper (1530)
  7. Correspondence (670)
  8. Guidelines (668)
  9. Research Letter (555)
  10. Book Whole (345)
  11. Miscellaneous (340)
Groups
  1. Department of Medicine (39131)
  2. GSK Faculty (22504)
  3. Solid Tumor Oncology Division (22118)
  4. Surgery (21313)
  5. Survivorship Research (15796)
  6. Sloan Kettering Institute Faculty (15666)

More Groups

People
  1. Marc Ladanyi (1329)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1053)

More People

Years
  1. 2026 (1)
  2. 2025 (2313)
  3. 2024 (5382)
  4. 2023 (5808)
  5. 2022 (6169)
  6. 2021 (5720)

More Years

Publications
  1. Journal of Clinical Oncology (8596)
  2. Blood (4954)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2614)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1814)

More Publications

Publishers
  1. Elsevier Inc. (13867)
  2. American Society of Clinical Oncology (9180)
  3. Springer (7201)
  4. Nature Publishing Group (6392)
  5. American Association for Cancer Research (6014)
  6. Elsevier Science, Inc. (5526)

More Publishers

Results (115781)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Antitumor activity of TAK-788 in NSCLC with EGFR exon 20 insertions
    Meeting Abstract

    Janne, P. A.; Neal, J. W.; Camidge, D. R.; Spira, A. I.; Piotrowska, Z.; Horn, L.; Costa, D. B.; Tsao, A. S.; Patel, J. D.; Gadgeel, S. M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Preemptive versus reactive topical clobetasol for regorafenib-induced hand-foot reactions: Results from the ReDOS trial
    Meeting Abstract

    Jatoi, A.; Ou, F. S.; Ahn, D. H.; Boland, P. M.; Ciombor, K. K.; Jacobs, N. L.; Pasche, B.; Cleary, J. M.; McCune, J. S.; Pedersen, K.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Trends in pancreatic cancer chemotherapy treatment in the United States from 2008 through 2016
    Meeting Abstract

    Hui, S.; Bernstein, D.; Balachandran, V. P.; Henk, H. J.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • FUZE clinical trial: A phase 2 study of Debio 1347 in FGFR fusion-positive advanced solid tumors irrespectively of tumor histology
    Meeting Abstract

    Hyman, D. M.; Goyal, L.; Grivas, P.; Meric-Bernstam, F.; Tabernero, J.; Hu, Y.; Kirpicheva, Y.; Nicolas-Metral, V.; Pokorska-Bocci, A.; Vaslin, A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • JAVELIN BRCA/ATM: A phase 2 trial of avelumab (anti-PD-L1) plus talazoparib (PARP inhibitor) in patients with advanced solid tumors with a BRCA1/2 or ATM defect
    Meeting Abstract

    Hyman, D. M.; Zelnak, A. B.; Bauer, T. M.; Ulahannan, S. V.; Ford, J. M.; Cesari, R.; Hoyle, M.; Chappey, C.; Stewart, R.; Conte, U.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Improving risk assessment of obesity-associated breast cancer
    Meeting Abstract

    Iyengar, N. M.; Gucalp, A.; Zhou, X. K.; Wang, H.; Giri, D. D.; Williams, S.; Falcone, D. J.; Winston, L.; Landa, J.; Kirstein, L. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Response to brentuximab vedotin by CD30 expression: Results from five trials in PTCL, CTCL, and B-cell lymphomas
    Meeting Abstract

    Jagadeesh, D.; Horwitz, S. M.; Bartlett, N. L.; Advani, R. H.; Jacobsen, E. D.; Duvic, M.; Gautam, A.; Rao, S.; Onsum, M.; Fanale, M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma
    Meeting Abstract

    Janjigian, Y. Y.; Maron, S. B.; Chou, J. F.; Gabler, A.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase Ia/b study of TIM-3/PD-L1 bispecific antibody in patients with advanced solid tumors
    Meeting Abstract

    Hellmann, M. D.; Shimizu, T.; Doi, T.; Hodi, F. S.; Rottey, S.; Aftimos, P. G.; Liu, Z. T.; de Mendizabal, N. V.; Szpurka, A. M.; Piao, Y.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Temporal trends among survivors of rhabdomyosarcoma: A report from the Childhood Cancer Survivor Study (CCSS)
    Meeting Abstract

    Hingorani, P.; Wang, M.; Srivastava, D.; Nathan, P. C.; Oeffinger, K. C.; Yasui, Y.; Leisenring, W. M.; Howell, R. M.; Mueller, E. L.; Gibson, T. M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save